Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
7m agoe.l.f. Cosmetics Joins the International Dance League as Founding Partner to Put Dancers Center Stage
38m agoTDG Gold Appoints Paul Geddes as Senior Vice-President Business Development and Strategy
38m agoMeryllion Resources Announces New Non-Brokered LIFE Financing
38m agoMkango Resources Announces Opening of Hypromag Plant in Pforzheim
38m agoAurania Resources Enters into Agreement with St-Georges to Jointly Advance the Thor Epithermal Gold Project in Iceland
Aurinia Pharmaceuticals Inc logo

Aurinia Pharmaceuticals Inc

About

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) — investor relations, events, news, and company updates on 6ix.

Latest News

Mar 30 2026
Aurinia Pharmaceuticals to Acquire Kezar Life Sciences for $6.955 in Cash per Share Plus a Contingent Value Right
Mar 23 2026
Aurinia Announces Management Transition
Feb 26 2026
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
Feb 19 2026
Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026
Dec 16 2025
Specific Biologics Welcomes Accomplished Biotechnology Leader Dr. Richard Glickman to its Board of Directors

Financials

Revenue
$283.06 M
Market Cap
$2.08 B
P/E Ratio
7.54
EPS
2.07

Community Chat

Ask AI

6ix6ix